Phase I and pharmacokinetic study of once-daily dosing of intravenously administered busulfan in the setting of a reduced-intensity preparative regimen and allogeneic hematopoietic stem cell transplantation as immunotherapy for renal cell carcinoma

Paul Shaughnessy, Warren Alexander, Hai Tran, David Ririe, James Splichal, Marilyn Pollack, Carlos Bachier, Charles LeMaistre

Research output: Contribution to journalArticlepeer-review

4 Scopus citations

Fingerprint

Dive into the research topics of 'Phase I and pharmacokinetic study of once-daily dosing of intravenously administered busulfan in the setting of a reduced-intensity preparative regimen and allogeneic hematopoietic stem cell transplantation as immunotherapy for renal cell carcinoma'. Together they form a unique fingerprint.

Medicine and Dentistry

Nursing and Health Professions

Chemistry

Pharmacology, Toxicology and Pharmaceutical Science